STERIS plc (STE) Comparison with companies in other sectors?

STERIS plc has a share price of 98.37M. You can analyze STERIS plc (STE) competitors across different market sectors through stock heatmaps.

What are STE's NET and operating margins?

STERIS plc (STE) operating margin is around 0.16, and net profit margin is approximately 0.11 as of the latest reports.

In what way does STE's earnings per share (EPS) trend reflect its financial momentum?

STERIS plc (STE) EPS is 6.16 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for STERIS plc is 36.14, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for STERIS plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for STERIS plc like P/E which is 35.68, P/B which is 3.32, and PEG which is 1.13. Compare them with sector averages to evaluate if the stock is priced fairly.

STERIS plc

STE•NYSE

Healthcare

Medical - Devices

$223.93

$-1.65(-0.73%)

Fundamental Analysis of STERIS plc (STE)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$6.16

P/E Ratio

36.14

ROE

0.09%

Net Margin

0.11%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$21.90B

Shares OutstandingTotal number of shares issued

$98.37M

Book Value/ShareNet worth per share

$67.32

Revenue/ShareAnnual revenue per share

$55.55

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$6.16

Net MarginNet income as percentage of revenue

11.26%

Operating MarginOperating income as percentage of revenue

15.87%

ROEReturn on shareholders' equity

9.46%

ROAReturn on total assets

6.06%

ROCEReturn on capital employed

9.50%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$7.94

Cash/ShareCash and equivalents per share

$1.75

FCF YieldFree cash flow as percentage of market cap

3.56%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$2.80

Dividend YieldAnnual dividend as percentage of stock price

1.26%

Financial Ratios Analysis data is not available for STEFinancial Ratios Analysis details for STE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for STESector Benchmarking details for STE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for STERIS plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of STERIS plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account STERIS plc's unique business strengths and challenges.

Key Financial Metrics for STERIS plc

For STERIS plc, essential financial indicators include EPS 6.16, PE 36.14, and ROE 0.09. These key ratios reveal insights into STERIS plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare STERIS plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of STERIS plc

Metrics like Net Margin 11.26% and ROA 6.06% shed light on how well STERIS plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether STERIS plc can sustain its operations and continue growing in the future.

Valuation and Market Position of STERIS plc

Using ratios such as P/B Ratio 3.32 and PEG Ratio 1.13, investors can assess whether STERIS plc is appropriately valued based on its financials and growth potential. These figures, combined with STERIS plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for STERIS plc

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow $7.94, provide a snapshot of STERIS plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like STERIS plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for STERIS plc

Investing in STERIS plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at STERIS plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;